alprenolol has been researched along with Cardiovascular Stroke in 61 studies
Alprenolol: One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
alprenolol : A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a group of 37 patients with definite acute myocardial infarction (AMI) allocated to treatment with either alprenolol (n = 20) or placebo (n = 17) serial determinations of concentrations in serum of myoglobin (S-Mb), creatine kinase (S-CK), aspartate aminotransferase (S-ASAT) and lactate dehydrogenase (S-LDH) were performed." | 9.05 | The effect of alprenolol on serum myoglobin levels in acute myocardial infarction. ( Christiansen, E; Kølendorf, K; Pedersen, F; Rasmussen, SL, 1984) |
| "A double-blind study of alprenolol versus placebo was done in patients with definite or suspected myocardial infarction to show the effect of the drug on mortality-rate after a year of treatment in patients aged less than or equal to 65 and to study the tolerance of the drug by patients greater than 65 years of age." | 9.04 | Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results. ( Andersen, MP; Bechsgaard, P; Frederiksen, J; Hansen, DA; Jürgensen, HJ; Nielsen, B; Pedersen, F; Pedersen-Bjergaard, O; Rasmussen, SL, 1979) |
| "The concentration of lipids, lipoproteins and apolipoprotein A-I and B was measured in the plasma of 33 patients, enrolled in a double-blind, controlled trial of alprenolol in myocardial infarction, after one year on the study medication and again after 6 months off the medication." | 5.06 | The long-term effect of alprenolol on plasma apolipoproteins A-I and B. ( Faergeman, O; Gerdes, LU; Groot, PH; Jürgensen, HJ, 1988) |
| "Serum levels of T4, T3 rT3 and resin T3 uptake were followed for 5 days in 40 patients with acute myocardial infarction (AMI) allocated to early treatment either with alprenolol or placebo." | 5.05 | "Low T3-syndrome" in acute myocardial infarction--relationship to beta-adrenergic blockade and clinical course. ( Pedersen, F; Perrild, H; Rasmussen, SL; Skovsted, L, 1984) |
| "In a group of 37 patients with definite acute myocardial infarction (AMI) allocated to treatment with either alprenolol (n = 20) or placebo (n = 17) serial determinations of concentrations in serum of myoglobin (S-Mb), creatine kinase (S-CK), aspartate aminotransferase (S-ASAT) and lactate dehydrogenase (S-LDH) were performed." | 5.05 | The effect of alprenolol on serum myoglobin levels in acute myocardial infarction. ( Christiansen, E; Kølendorf, K; Pedersen, F; Rasmussen, SL, 1984) |
| "Two hundred and eighty-two patients less than 66 years of age admitted with suspected or definite myocardial infarction were allocated in a random fashion to treatment with alprenolol or placebo." | 5.05 | Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol. ( Frederiksen, J; Hansen, DA; Jürgensen, JH; Pedersen-Bjergaard, O, 1981) |
| "A double-blind study of alprenolol versus placebo was done in patients with definite or suspected myocardial infarction to show the effect of the drug on mortality-rate after a year of treatment in patients aged less than or equal to 65 and to study the tolerance of the drug by patients greater than 65 years of age." | 5.04 | Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results. ( Andersen, MP; Bechsgaard, P; Frederiksen, J; Hansen, DA; Jürgensen, HJ; Nielsen, B; Pedersen, F; Pedersen-Bjergaard, O; Rasmussen, SL, 1979) |
| "The author describes the notions that led to initiation of controlled trials of long-term medication with antiarrhythmic drugs following myocardial infarction, and reviews reports of controlled trials with diphenylhydantoin, alprenolol, and procaine amide." | 3.65 | Arrhythmia prophylaxis: Long-term suppressive medication. ( Lovell, RR, 1975) |
| "The incidences of congestive heart failure, hypotension, AV blocks and ventricular arrhythmias were not significantly more common in the control group (8 vs." | 2.65 | Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits. ( Berglund, U; Dahlström, U; Karlsson, E, 1980) |
| "Alprenolol and placebo were gradually withdrawn over 14 days." | 2.65 | Long-term alprenolol treatment affects serum T4, T3 and rT3 in euthyroid patients with ischaemic heart disease. ( Jürgensen, HJ; Pedersen, F; Perrild, H; Rasmussen, SL; Skovsted, L, 1984) |
| "The effect is critically reviewed of chronic administration of beta-adrenoreceptor antagonists on morbidity and mortality in angina pectoris and myocardial infarction." | 1.26 | The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease. ( Fitzgerald, JD, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 61 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frishman, WH | 3 |
| Dahlström, U | 1 |
| Berglund, U | 1 |
| Karlsson, E | 1 |
| Gendenshteĭn, EI | 1 |
| Sernov, LN | 1 |
| Schröder, R | 1 |
| Hampton, JR | 2 |
| Vedin, A | 8 |
| Wilhelmsson, C | 7 |
| Frick, MH | 1 |
| Katila, M | 1 |
| Hjalmarson, A | 1 |
| Jürgensen, HJ | 12 |
| Meinertz, H | 1 |
| Faergeman, O | 2 |
| Moss, AJ | 1 |
| Pratt, CM | 1 |
| Roberts, R | 1 |
| Furberg, CD | 2 |
| Friedewald, WT | 2 |
| Tomov, I | 1 |
| Pedersen, F | 10 |
| Perrild, H | 2 |
| Rasmussen, SL | 10 |
| Skovsted, L | 2 |
| Frederiksen, J | 7 |
| Hansen, DA | 8 |
| Pedersen-Bjergaard, O | 8 |
| Andersen, MP | 3 |
| Bechsgaard, P | 5 |
| Nielsen, PB | 4 |
| Kølendorf, K | 1 |
| Christiansen, E | 1 |
| Jürgensen, JH | 1 |
| Kanazawa, T | 1 |
| Matsuoka, H | 1 |
| May, GS | 1 |
| DeMets, DL | 1 |
| Friedman, LM | 1 |
| Furberg, C | 1 |
| Passamani, E | 1 |
| Norris, RM | 1 |
| Fitzgerald, JD | 1 |
| Chamberlain, DA | 1 |
| Wilkinson, RK | 1 |
| Fanchamps, A | 1 |
| Andersen, M | 1 |
| Lovell, RR | 1 |
| Schroeder, JS | 1 |
| Nielsen, B | 1 |
| Ahlmark, G | 3 |
| Saetre, H | 3 |
| Nyberg, G | 2 |
| Werkö, L | 4 |
| Tibblin, G | 3 |
| Wilhelmsen, L | 3 |
| Wihelmsson, C | 1 |
| Wedel, H | 1 |
| Wilhelmson, C | 1 |
| Björntorp, P | 1 |
| Vedin, JA | 2 |
| Wilhelmsson, CE | 1 |
| Wood, M | 1 |
| Gerdes, LU | 1 |
| Groot, PH | 1 |
| Reynolds, JL | 1 |
| Whitlock, RM | 1 |
| Korsgren, M | 1 |
| Gettes, LS | 1 |
| Harrison, DC | 1 |
| Singh, BN | 1 |
| Jewitt, DE | 1 |
| Keyriläinen, O | 1 |
| Uusitalo, AJ | 1 |
| Lemberg, L | 1 |
| Arcebal, AG | 1 |
| Castellanos, A | 1 |
| Slavin, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for alprenolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudd | 1980 |
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibr | 1981 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Fe | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial In | 1984 |
[Myocardial infarct: secondary prevention with drugs and their effects].
Topics: Alprenolol; Aspirin; Dipyridamole; Humans; Myocardial Infarction; Prognosis; Sulfinpyrazone | 1980 |
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Huma | 1981 |
[Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Humans; Hy | 1978 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Ca | 1986 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillatio | 1970 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; | 1974 |
45 trials available for alprenolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudd | 1980 |
Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Femal | 1980 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Fe | 1981 |
Beta blockade and the secondary prevention of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Female | 1981 |
Beta blockers after myocardial infarction--aspects on study design based on current knowledge.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Clinical Trials as Topic; Female; Humans; Male; Middl | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Plasma lipids and lipoproteins in long-term beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Alprenolol; Cholesterol; Clinical Trials as Topic; Double-Blind Method; | 1982 |
Postinfarction therapy with beta blockers: who should be treated?
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Heart; Human | 1982 |
Chronic beta blockade therapy in patients after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Humans | 1983 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial In | 1984 |
"Low T3-syndrome" in acute myocardial infarction--relationship to beta-adrenergic blockade and clinical course.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Female; Humans; Male; Middle Aged; Myocardial Infarct | 1984 |
Long-term alprenolol treatment affects serum T4, T3 and rT3 in euthyroid patients with ischaemic heart disease.
Topics: Adult; Aged; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle | 1984 |
Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Background and aims of the study.
Topics: Alprenolol; Clinical Trials as Topic; Double-Blind Method; Humans; Myocardial Infarction; Random All | 1984 |
Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Salvage of ischaemic myocardium by alprenolol.
Topics: Aged; Alprenolol; Blood Pressure; Clinical Trials as Topic; Creatine Kinase; Electrocardiography; He | 1984 |
Prophylactic effect of alprenolol on ventricular tachyarrhythmias during the in-patient phase of acute myocardial infarction.
Topics: Aged; Alprenolol; Anti-Arrhythmia Agents; Clinical Trials as Topic; Drug Therapy, Combination; Elect | 1984 |
Short-term and long-term tolerance to beta-blockade with alprenolol in patients admitted for a suspected acute myocardial infarction.
Topics: Administration, Oral; Aged; Alprenolol; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Top | 1984 |
Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Causes of death and post-mortem findings with special reference to early deaths.
Topics: Aged; Alprenolol; Autopsy; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myocardial I | 1984 |
Use of alprenolol in the secondary prevention of myocardial infarction.
Topics: Age Factors; Aged; Alprenolol; Clinical Trials as Topic; Death, Sudden; Humans; Middle Aged; Myocard | 1984 |
Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study.
Topics: Adult; Aged; Alprenolol; Clinical Trials as Topic; Data Collection; Denmark; Double-Blind Method; Fe | 1984 |
The effect of long-term intervention with alprenolol on mortality in definite or suspected myocardial infarction.
Topics: Aged; Alprenolol; Clinical Trials as Topic; Follow-Up Studies; Humans; Long-Term Care; Middle Aged; | 1984 |
The effect of alprenolol on serum myoglobin levels in acute myocardial infarction.
Topics: Adult; Aged; Alprenolol; Aspartate Aminotransferases; Creatine Kinase; Female; Humans; L-Lactate Deh | 1984 |
Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.
Topics: Aged; Alprenolol; Clinical Trials as Topic; Creatine Kinase; Double-Blind Method; Humans; Middle Age | 1981 |
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Huma | 1981 |
Beta-adrenergic blocking agents in prevention of sudden death.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Death, Sudden; Dru | 1978 |
[Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Humans; Hy | 1978 |
[Reduction of mortality in acute myocardial infarction in patients treated with alprenolol. Preliminary results].
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Humans | 1979 |
Beta-blockers after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Humans; Myoc | 1979 |
Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results.
Topics: Acute Disease; Administration, Oral; Aged; Alprenolol; Clinical Trials as Topic; Follow-Up Studies; | 1979 |
Long-term treatment with beta-blockers after myocardial infarction.
Topics: Adult; Aged; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Cardiomegaly; Clinic | 1976 |
Laboratory analyses during two years' treatment with alprenolol in patients with myocardial infarction.
Topics: Aged; Alanine Transaminase; Alprenolol; Aspartate Aminotransferases; Bilirubin; Blood Proteins; Chol | 1975 |
QT time in patients treated with alprenolol or placebo after myocardial infarction.
Topics: Aged; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Heart; | 1979 |
[Effect of alprenolol on the extent myocardial infarction assessed by serial determination of serum creatine kinase].
Topics: Aged; Alprenolol; Clinical Trials as Topic; Creatine Kinase; Humans; Myocardial Infarction; Placebos | 1979 |
Chronic alprenolol treatment of patients with acute myocardial infarction after discharge from hospital.
Topics: Acute Disease; Aged; Alprenolol; Clinical Trials as Topic; Diabetes Complications; Female; Humans; L | 1975 |
[Reduction of sudden death after myocardial infarct with chronic alprenolol treatment].
Topics: Alprenolol; Clinical Trials as Topic; Follow-Up Studies; Humans; Myocardial Infarction; Placebos | 1975 |
Deaths and non-fatal reinfarctions during two years' follow-up.
Topics: Aged; Alprenolol; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; My | 1975 |
Angina pectoris, hypertension, decompensation and return to work during two years' follow-up.
Topics: Aged; Alprenolol; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Disability Evaluation; | 1975 |
Induction of diabetes and oral glucose tolerance tests during and after chronic beta-blockade.
Topics: Aged; Alprenolol; Blood Glucose; Cholesterol; Clinical Trials as Topic; Diabetes Complications; Diab | 1975 |
Letter: Positon of myocardial infarct and results of alprenolol treatment.
Topics: Alprenolol; Death, Sudden; Humans; Myocardial Infarction | 1976 |
The long-term effect of alprenolol on plasma apolipoproteins A-I and B.
Topics: Adult; Aged; Alprenolol; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Clinical Trials a | 1988 |
Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
Topics: Alprenolol; Amino Alcohols; Angina Pectoris; Blood Pressure; Cardiac Complexes, Premature; Clinical | 1972 |
Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results.
Topics: Age Factors; Aged; Alprenolol; Clinical Trials as Topic; Coronary Care Units; Death, Sudden; Female; | 1974 |
Letter: Reduction of sudden Deaths after myocardial infarction.
Topics: Aged; Alprenolol; Death, Sudden; Follow-Up Studies; Humans; Myocardial Infarction; Recurrence | 1974 |
Effects of alprenolol and isosorbide dinitrate in angina pectoris. A comparative study with methodological considerations.
Topics: Activities of Daily Living; Adult; Aged; Alprenolol; Angina Pectoris; Electrocardiography; Female; F | 1973 |
11 other studies available for alprenolol and Cardiovascular Stroke
| Article | Year |
|---|---|
[Effect of the beta-adrenoblocker alpheprol and the alpha-adrenolytic tropaphen on tolerance to strophanthin in experimental myocardial infarct].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Arrhythmias, Cardiac | 1980 |
[Beta blockage after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Humans; Myocardial Infarction; Practolol; Propranolol; Time | 1982 |
Prophylactic antiarrhythmic drugs after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Age Factors; Alprenolol; Anti-Arrhythmia Agents; Humans; Middle Aged; M | 1976 |
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Animals; Coronary Disease; Dogs; Follow-Up | 1976 |
The role of long term beta-blockade after myocardial infarction: Paper 3.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Humans; Myocardial Infarction; Practolol; | 1978 |
[Clinical experiences with acute beta blockade in acute myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Arrhythmias, Cardiac; Female; Heart Block; Hum | 1979 |
Arrhythmia prophylaxis: Long-term suppressive medication.
Topics: Acute Disease; Aged; Alprenolol; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Diseas | 1975 |
Should premature ventricular beats be treated in the ambulatory patient? A protagonist's view.
Topics: Adult; Aged; Alprenolol; Ambulatory Care; Cardiac Complexes, Premature; Death, Sudden; Electrocardio | 1977 |
Letter: Long-term postinfarction treatment with practolol.
Topics: Alprenolol; Blood Pressure; Humans; Myocardial Infarction; Practolol | 1975 |
Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiovascular Disea | 1974 |
Use of alprenolol in acute cardiac arrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Amino Alcohols; Arrhythmias, Cardi | 1972 |